« Previous
Next »
American Journal of Ophthalmology
Volume 142, Issue 4
, Pages 576.e1-576.e8
, October 2006
Baseline Optical Coherence Tomography Predicts the Development of Glaucomatous Change in Glaucoma Suspects
References
- Discriminating between normal and glaucomatous eyes using the Heidelberg retina tomograph, GDx nerve fiber analyzer, and optical coherence tomograph . Arch Ophthalmol . 2001;119:985–993
- Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography . Arch Ophthalmol . 1995;113:586–596
- . Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma . Invest Ophthalmol Vis Sci . 2002;43:140–145
- . Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes . Am J Ophthalmol . 2000;129:129–135
- Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma . Arch Ophthalmol . 2005;123:464–470
- . An evaluation of optic disk and nerve fiber layer examinations in monitoring progression of early glaucoma damage . Ophthalmology . 1992;99:19–28
- . The nerve fiber layer in the diagnosis of glaucoma . Arch Ophthalmol . 1977;95:2149–2156
- . Optic nerve damage in human glaucoma. III (Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy) . Arch Ophthalmol . 1982;100:135–146
- Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss . Arch Ophthalmol . 1991;109:77–83
- Optical coherence tomography of the human retina . Arch Ophthalmol . 1995;113:325–332
- Optical coherence tomography: a new tool for glaucoma diagnosis . Curr Opin Ophthalmol . 1995;6:89–95
- . Optical coherence tomography to detect and manage retinal disease and glaucoma . Am J Ophthalmol . 2004;137:156–169
- The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma . Ophthalmology . 2002;109:432–437
- . Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy . Am J Ophthalmol . 2003;136:805–813
-
.
Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss
.
Am J Ophthalmol
. 2004;138:593–601
- Confocal scanning laser ophthalmoscopy classifiers and stereophotograph evaluation for prediction of visual field abnormalities in glaucoma-suspect eyes . Invest Ophthalmol Vis Sci . 2004;45:2255–2262
- . Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss . Am J Ophthalmol . 2004;137:863–871
- . Retinal nerve fiber layer thickness in normal human eyes . Ophthalmology . 1996;103:2114–2119
- . The contour of the juxtapapillary nerve fiber layer in glaucoma . Ophthalmology . 1990;97:358–365
- . Comparison of algorithms for detection of localized nerve fiber layer defects using scanning laser polarimetry . Br J Ophthalmol . 2003;87:413–419
- . Use of progressive glaucomatous optic disk change as the reference standard for evaluation of diagnostic tests in glaucoma . Am J Ophthalmol . 2005;139:1010–1018
- . Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study . Arch Ophthalmol . 2000;118:1187–1194
- . Comparability of retinal nerve fiber layer thickness measurements of optical coherence tomography instruments . Invest Ophthalmol Vis Sci . 2005;46:1280–1285
- . Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes . Invest Ophthalmol Vis Sci . 2005;46:2440–2443
- Baseline topographic optic disk measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study . Arch Ophthalmol . 2005;123:1188–1197
- Heidelberg retina tomograph measurements of the optic disk and parapapillary retina for detecting glaucoma analyzed by machine learning classifiers . Invest Ophthalmol Vis Sci . 2004;45:3144–3151
Supported in part by NIH Grants EY11008 (LMZ), EY08208 (PAS), and MEC/CAPES grant BEX2230/04-6 (IMT). Participant retention incentive grants in the form of glaucoma medication at no cost: Alcon Laboratories Inc (Fort Worth, Texas), Allergan (Irvine, California), Pfizer Inc (New York, New York), and SANTEN Inc (Napa, California).
PII: S0002-9394(06)00580-0
doi: 10.1016/j.ajo.2006.05.004
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Ophthalmology
Volume 142, Issue 4
, Pages 576.e1-576.e8
, October 2006
